|
2.5 Etiologie - Gènes
|
|
|
|
3.7 Alcool
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
|
5.12.3 Immunothérapies-combinaisons
|
|
|
|
5.12.6 Immunothérapies - AMM
|
|
|
|
5.2 Pharma
|
|
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
|
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
|
|
Bavencio [EMA]
|
|
|
|
|
|
The
Committee for Medicinal Products for Human Use (CHMP) adopted a
positive opinion, recommending the granting of a marketing authorisation
for the medicinal product Bavencio, intended for the treatment of
metastatic Merkel cell carcinoma.
|
|
|
|
|
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
|
6.3 Associations/Fondations
|
|
|
|
|
6.9 Controverses
|
|
|